(Q43206360)

16 November 2017

Metallothionein-I + II and receptor megalin are altered in relation to oxidative stress in cerebral lymphomas (English)

1 reference

16 November 2017

4

Milena Penkowa

0 references

Mie Østergaard Pedersen

series ordinal

1

object named as

Mie Ø Pedersen

0 references

author name string

Per B Hansen

series ordinal

2

1 reference

PubMed ID

20038220

16 November 2017

Signe L Nielsen

series ordinal

3

1 reference

16 November 2017

1 February 2010

1 reference

16 November 2017

1 reference

16 November 2017

51

1 reference

16 November 2017

2

1 reference

16 November 2017

314-328

1 reference

Biology and treatment of primary central nervous system lymphoma

16 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Therapeutic challenges in primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

The role of metallothionein in oncogenesis and cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Insights into the biology of primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Primary CNS lymphoma in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein as a useful marker in Hodgkin lymphoma subclassification.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Cell death in the injured brain: roles of metallothioneins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothioneins are multipurpose neuroprotectants during brain pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Microarray-based classification of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

The possible biological role of metallothionein in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein 1 is a downstream target of vascular endothelial zinc finger 1 (VEZF1) in endothelial cells and participates in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Interaction of metallothionein with tumor suppressor p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein: A Multifunctional Protein from Toxicity to Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein expression in human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

The renal metallothionein expression profile is altered in human lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein-I+II in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein-IIA promotes neurite growth via the megalin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Prognostic significance of metallothionein in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 2005;54:3089-3094

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903518329

10.3109/10428190903518329

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference

PubMed ID

20038220